ATE250077T1 - Steroid sulfataseinhibitoren, verfahren zu ihrer herstellung und verwendung - Google Patents

Steroid sulfataseinhibitoren, verfahren zu ihrer herstellung und verwendung

Info

Publication number
ATE250077T1
ATE250077T1 AT98936825T AT98936825T ATE250077T1 AT E250077 T1 ATE250077 T1 AT E250077T1 AT 98936825 T AT98936825 T AT 98936825T AT 98936825 T AT98936825 T AT 98936825T AT E250077 T1 ATE250077 T1 AT E250077T1
Authority
AT
Austria
Prior art keywords
production
steroid sulfatase
sulfatase inhibitors
compounds
inhibitors
Prior art date
Application number
AT98936825T
Other languages
English (en)
Inventor
Pui-Kai Li
Kyle W Selcer
Original Assignee
Univ Holy Ghost Duquesne
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Univ Holy Ghost Duquesne filed Critical Univ Holy Ghost Duquesne
Application granted granted Critical
Publication of ATE250077T1 publication Critical patent/ATE250077T1/de

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07J—STEROIDS
    • C07J41/00—Normal steroids containing one or more nitrogen atoms not belonging to a hetero ring
    • C07J41/0005—Normal steroids containing one or more nitrogen atoms not belonging to a hetero ring the nitrogen atom being directly linked to the cyclopenta(a)hydro phenanthrene skeleton
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P35/00—Antineoplastic agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P5/00—Drugs for disorders of the endocrine system
    • A61P5/24—Drugs for disorders of the endocrine system of the sex hormones
    • A61P5/32—Antioestrogens
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07J—STEROIDS
    • C07J41/00—Normal steroids containing one or more nitrogen atoms not belonging to a hetero ring
    • C07J41/0033—Normal steroids containing one or more nitrogen atoms not belonging to a hetero ring not covered by C07J41/0005
    • C07J41/0072—Normal steroids containing one or more nitrogen atoms not belonging to a hetero ring not covered by C07J41/0005 the A ring of the steroid being aromatic

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Public Health (AREA)
  • Medicinal Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Chemical & Material Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Diabetes (AREA)
  • Endocrinology (AREA)
  • Steroid Compounds (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
AT98936825T 1997-07-18 1998-07-08 Steroid sulfataseinhibitoren, verfahren zu ihrer herstellung und verwendung ATE250077T1 (de)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US08/897,247 US5880115A (en) 1997-07-18 1997-07-18 Steroid sulfatase inhibitors and methods for making and using the same
PCT/US1998/014206 WO1999003876A1 (en) 1997-07-18 1998-07-08 Steroid sulfatase inhibitors and methods for making and using the same

Publications (1)

Publication Number Publication Date
ATE250077T1 true ATE250077T1 (de) 2003-10-15

Family

ID=25407613

Family Applications (1)

Application Number Title Priority Date Filing Date
AT98936825T ATE250077T1 (de) 1997-07-18 1998-07-08 Steroid sulfataseinhibitoren, verfahren zu ihrer herstellung und verwendung

Country Status (8)

Country Link
US (1) US5880115A (de)
EP (1) EP1009755B1 (de)
JP (1) JP2001510200A (de)
AT (1) ATE250077T1 (de)
AU (1) AU729325B2 (de)
CA (1) CA2296498A1 (de)
DE (1) DE69818278T2 (de)
WO (1) WO1999003876A1 (de)

Families Citing this family (23)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US6476011B1 (en) * 1991-08-28 2002-11-05 Sterix Limited Methods for introducing an estrogenic compound
US6011024A (en) 1991-08-28 2000-01-04 Imperial College Of Science Technology & Medicine Steroid sulphatase inhibitors
GB9118478D0 (en) * 1991-08-29 1991-10-16 Imperial College Steroid sulphatase inhibitors
US6376687B1 (en) * 1997-07-18 2002-04-23 Duquesne University Of The Holy Ghost Steroid sulfatase inhibitors and methods for making and using the same
US6288050B1 (en) * 1997-07-18 2001-09-11 Duquesne University Of The Holy Ghost Steroid sulfatase inhibitors and methods for making and using the same
ATE473759T1 (de) 1998-05-22 2010-07-15 Univ Leland Stanford Junior Bifunktionelle moleküle sowie darauf basierende therapien.
ATE401896T1 (de) 1998-06-10 2008-08-15 Sterix Ltd Pharmazeutische zusammensetzungen mit tumor nekrose faktor und 2-methoxyestron-3-o-sulphamat als estrone sulphatasehemmern
US6248780B1 (en) 1998-10-01 2001-06-19 Duquesne University Of The Holy Ghost Compounds for the treatment of estrogen-dependent illnesses and methods for making and using the same
JP2000309599A (ja) * 1999-04-13 2000-11-07 Kyowa Hakko Kogyo Co Ltd エストラ−１，３，５（１０），１６−テトラエン誘導体
US7078395B1 (en) 1999-06-16 2006-07-18 Sterix Limited Methods for treating or preventing cancer by preventing, inhibiting or arresting cell cycling
JP5042411B2 (ja) 1999-04-30 2012-10-03 ステリックス リミテッド 抗腫瘍剤としてのエストロン誘導体の使用
US7335650B2 (en) * 2000-01-14 2008-02-26 Sterix Limited Composition
EP1284272A4 (de) * 2000-04-24 2003-09-10 Kyowa Hakko Kogyo Kk Östra-1,3,5(10)-trienderivate
GB0025788D0 (en) * 2000-10-20 2000-12-06 Sterix Ltd Use
CA2430288C (en) 2000-12-01 2009-03-10 Kyowa Hakko Kogyo Co., Ltd. A composition improved in the solubility or oral absorbability
AU2002322720B2 (en) 2001-07-25 2008-11-13 Raptor Pharmaceutical Inc. Compositions and methods for modulating blood-brain barrier transport
US8026229B2 (en) * 2001-08-13 2011-09-27 Sterix Limited Antitumor-active 2-alkoxyestradiol sulfamates
GB0306718D0 (en) * 2003-03-24 2003-04-30 Sterix Ltd Compound
CN102379684B (zh) 2005-04-28 2014-11-19 普罗透斯数字保健公司 药物信息系统
US9062126B2 (en) 2005-09-16 2015-06-23 Raptor Pharmaceuticals Inc. Compositions comprising receptor-associated protein (RAP) variants specific for CR-containing proteins and uses thereof
EP2398500B1 (de) 2009-02-20 2019-03-13 2-BBB Medicines B.V. Arzneiabgabesystem auf glutathion-basis
ES2942923T3 (es) 2009-05-06 2023-06-07 Laboratory Skin Care Inc Composiciones de administración dérmica que comprenden complejos de agente activo-partículas de fosfato de calcio y métodos de uso de las mismas
CN111647037B (zh) * 2020-06-02 2021-12-07 南宁师范大学 17-酰胺雌甾类化合物及其制备方法和应用

Family Cites Families (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE86393C (de) *
GB9118478D0 (en) * 1991-08-29 1991-10-16 Imperial College Steroid sulphatase inhibitors
US5556847A (en) * 1994-10-27 1996-09-17 Duquesne University Of The Holy Ghost Methods of effecting memory enhancement mediated by steroid sulfatase inhibitors
US5571933A (en) * 1994-11-17 1996-11-05 Duquesne University Of The Holy Ghost Derivatives of estra 1,3,5(10)triene-17-one, 3-amino compounds and their use
US5567831A (en) * 1995-08-16 1996-10-22 Duguesne University Of The Holy Ghost Non-steroidal sulfatase inhibitor compounds and their method of use

Also Published As

Publication number Publication date
CA2296498A1 (en) 1999-01-28
AU8568798A (en) 1999-02-10
EP1009755A4 (de) 2002-11-06
EP1009755A1 (de) 2000-06-21
US5880115A (en) 1999-03-09
WO1999003876A1 (en) 1999-01-28
JP2001510200A (ja) 2001-07-31
DE69818278D1 (de) 2003-10-23
AU729325B2 (en) 2001-02-01
DE69818278T2 (de) 2004-04-08
EP1009755B1 (de) 2003-09-17

Similar Documents

Publication Publication Date Title
EP1009755A4 (de) Steroid sulfataseinhibitoren, verfahren zu ihrer herstellung und verwendung
DE69917833D1 (de) Substituierte Karbazole, Verfahren zu ihrer Herstellung und ihre Verwendung als sPLA2- Inhibitoren
ATE233762T1 (de) Bicyclische polyamiosaure metallkomplexe, verfahren zu ihrer herstellung und ihre verwendung für medizinische bilderzeugung
EA200001129A2 (ru) Способ получения 4-карбоксиамино-2-замещенного-1,2,3,4-тетрагидрохинолина
ATE311363T1 (de) Sulfohydroxamsäure and sulfohydroxamate und ihre verwendung als mek-inhibitoren
NO20006645D0 (no) Ny form av irbesartan, fremgangsmåte for å oppnå den nevnte form og farmasöytiske preparater inneholdende den samme
DE69113155D1 (de) 17-beta-substituierte-4-aza-5-alpha-androstan-3-one-derivate und verfahren zu ihrer herstellung.
DE69928655D1 (de) Substituierte porphyrine
DE69838146D1 (de) Androgene steroidderivate und ein verfahren zur herstellung und verwendung derselben
ATE266030T1 (de) 1,4,7,10-tetraazabicyclo(8.2.2)tetradecan-2-on, verfahren zu ihrer herstellung und ihrer verwendung für die herstellung von tetraazamacrocyclen
ATE338056T1 (de) Steroid sulfataseinhibitoren, verfahren zu ihrer herstellung und ihre verwendung
DE69632193D1 (de) Cyclooxygenaseinhibitor und salze von amidinderivaten, verfahren zu deren herstellung, deren verwendung als arzneiwirkstoffe sowie diese salze enthaltende arzneimittel
DE69816731D1 (de) Benzofuranon-derivate und verfahren zu ihrer herstellung
DE69905326D1 (de) Sollerschlitz und Verfahren zu dessen Herstellung
CA2421990A1 (en) .beta.-thioamino acids
DE50104557D1 (de) Neue beta-amyloid inhibitoren, verfahren zu deren herstellung und deren verwendung als arzneimittel
DE69819457D1 (de) Phosphorsäureester, Verfahren zu seiner Herstellung und Verwendung davon
ATE248021T1 (de) Lagerstabile belüftete gelzusammensetzung und verfahren zu dessen herstellung
EP0909172A4 (de) Verfahren und zusammensetzungen zur behandlung von harninkontinenz unter verwendung von enantiomer-angereichertem (r,s)-glycopyrrolat
DE50012584D1 (de) Keramikhaltiges dispergat, verfahren zu dessen herstellung und verwendung des dispergates in dickschichtpasten
DE69808771D1 (de) Ein verfahren zur herstellung von tetraaza makrocyclen
ATE238779T1 (de) Steroidhaltiges pflaster, verfahren zu seiner herstellung und verwendung
ATE244706T1 (de) Enantiomere von mercaptolactonen und verfahren zu ihrer herstellung
ATE267206T1 (de) 5-imino-13-deoxy-antracyclin-derivate, ihre verwendung sowie verfahren zu deren herstellung
ATE327227T1 (de) Klainetine und ihre derivate, verfahren zu ihrer herstellung und verwendung derselben

Legal Events

Date Code Title Description
RER Ceased as to paragraph 5 lit. 3 law introducing patent treaties